<--- Back to Details
First PageDocument Content
Mantle cell lymphoma / Medicine / Ohio / B-cell chronic lymphocytic leukemia / James Cancer Hospital / NCI-designated Cancer Center / Arthur G. James
Mantle cell lymphoma
Medicine
Ohio
B-cell chronic lymphocytic leukemia
James Cancer Hospital
NCI-designated Cancer Center
Arthur G. James

One University. One Cancer Program.

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 1.010,30 KB

Share Document on Facebook

Similar Documents

Assessment RunCD23 Material The slide to be stained for CD23 comprised: 1-2. Tonsil, 3. Mantle cell lymphoma, 4-5. B-CLL.

DocID: 1v4zE - View Document

CanFasterProject titles, research subjects and special requirements 1. Molecular investigations of mantle cell lymphoma and development of companion diagnostic tools Research subject: Immunotechnology Special requirement

DocID: 1tT6j - View Document

Biology / Chemistry / Molecular biology / Polymerase chain reaction / Biochemistry / Laboratory techniques / Biotechnology / Amplifiers / Ficoll / Agarose gel electrophoresis / DNA extraction / Laboratory centrifuge

KIT FOR MOLECULAR STUDY OF TRANSLOCATION t(11;14) Nº CAT. MAD-003998MDETERMINATIONS) Mantle cell lymphomas are a sub-type of non-Hodgkin’s lymphoma derived from a subset of virgin B-cells localised in the man

DocID: 1o1JJ - View Document

landmarks Reports from the American Society of Hematology Annual Meeting Mantle cell lymphoma HIGH-DOSE CYTARABINE (ARA-C) IMPROVES OS

DocID: 1d3F5 - View Document

Orphan drugs / Hematologic neoplasms / Multiple myeloma / Lenalidomide / International Myeloma Working Group / Plasma cell leukemia / Carfilzomib / Mantle cell lymphoma / Monoclonal gammopathy of undetermined significance / Medicine / Immunosuppressants / Phthalimides

REVIEW Continuous therapy with lenalidomide in multiple myeloma by Nizar Bahlis, MD

DocID: 1aydF - View Document